---
$id: https://graph.org.ai/products/commodity/51182034
$type: Product
source: UNSPSC
code: "51182034"
title: "Mibolerone"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mibolerone

**UNSPSC Code**: 51182034
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic androgen with the molecular formula C20H30O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9OGY4BOR8D, chemically known as 19-nortestosterone, 7alpha,17-dimethyl- but generally known as mibolerone, which bears US NIH Compound Identifier 19454. European Medicines Agency schedules Mibolerone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08941MIG. The term MIBOLERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). MIBOLERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mibolerone under HS 29372900 and SITC 54153. As of Q4 2014, MIBOLERONE remains the US FDA Preferred Term for this commodity. Mibolerone bears US NLM identifiers UMLS ID C0066502 and NCI Concept Code C72100. SMILES: OC1(C2(C(C3C(CC2)C2C(=CC(=O)CC2)CC3C)CC1)C)C.

